1. Home
  2. CDZI vs NGEN Comparison

CDZI vs NGEN Comparison

Compare CDZI & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.45

Market Cap

413.8M

Sector

Utilities

ML Signal

HOLD

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$3.85

Market Cap

337.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CDZI
NGEN
Founded
1983
2017
Country
United States
Canada
Employees
31
14
Industry
Water Supply
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
413.8M
337.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDZI
NGEN
Price
$4.45
$3.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
625.2K
235.3K
Earning Date
05-13-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.97
N/A
Revenue Next Year
$102.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.58
$3.51
52 Week High
$6.96
$5.93

Technical Indicators

Market Signals
Indicator
CDZI
NGEN
Relative Strength Index (RSI) 37.12 43.41
Support Level $4.18 $3.65
Resistance Level $5.17 $4.44
Average True Range (ATR) 0.22 0.20
MACD -0.03 -0.03
Stochastic Oscillator 7.85 15.25

Price Performance

Historical Comparison
CDZI
NGEN

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: